Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 4/2008

01-08-2008 | Commentary

Recently published papers: Renal replacement therapy: which route and how much? Intracerebral haematomas: does the size matter? beta blockers and steroids: will we ever know?

Authors: Vlad Kushakovsky, Richard Venn

Published in: Critical Care | Issue 4/2008

Login to get access

Abstract

Femoral access for renal replacement therapy appears to have a similar infection rate to jugular access. High-intensity renal support does not seem to improve mortality or length of hospital stay. Acute kidney injury as defined by Acute Kidney Injury Network predicts increased hospital mortality. Recombinant factor VIIa reduces growth of volume of intracerebral haematoma but does not affect clinical outcome. Sustained released metoprolol reduces perioperative cardiac events in non-cardiac surgery but leads to more deaths and strokes. Steroids are probably not beneficial in either children with non-Haemophilus influenzae type b bacterial meningitis, or in prophylaxis of acute respiratory distress syndrome (ARDS), but could be beneficial in the treatment of ARDS.
Literature
1.
Parienti JJ, Thirion M, Mégarbane B, Souweine B, Ouchikhe A, Polito A, Forel JM, Marqué S, Misset B, Airapetian N, Daurel C, Mira JP, Ramakers M, du Cheyron D, Le Coutour X, Daubin C, Charbonneau P, Members of the Cathedia Study Group: Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008, 299: 2413-2422. 10.1001/jama.299.20.2413CrossRefPubMed
2.
The VA/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359: 7-20. 10.1056/NEJMoa0802639PubMedCentralCrossRef
3.
Ostermann M, Chang RW: Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007, 35: 1837-1843. 1852. 10.1097/01.CCM.0000277041.13090.0ACrossRefPubMed
4.
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352: 777-785. 10.1056/NEJMoa042991CrossRefPubMed
5.
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, the FAST Trial Investigators: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358: 2127-2137. 10.1056/NEJMoa0707534CrossRefPubMed
6.
Tuhrim S: Intracerebral hemorrhage – improving outcome by reducing volume? N Engl J Med 2008, 358: 2174-2176. 10.1056/NEJMe0801856CrossRefPubMed
7.
POISE Study Group: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008, 371: 1839-1847. 10.1016/S0140-6736(08)60601-7CrossRef
8.
Fleisher LA, Poldermans D: Perioperative β blockade: where do we go from here? Lancet 2008, 371: 1813-1814. 10.1016/S0140-6736(08)60662-5CrossRefPubMed
9.
London MJ: Quo vadis, perioperative beta blockade? Are you "POISE'd" on the brink? Anesth Analg 2008, 106: 1025-1030.CrossRefPubMed
10.
Poldermans D, Bax JJ, Schouten O, Neskovic AN, Paelinck B, Rocci G, van Dortmont L, Durazzo AE, Ven LL, van Sambeek MR, Kertai MD, Boersma E, Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group: Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 2006, 48: 964-969. 10.1016/j.jacc.2006.03.059CrossRefPubMed
11.
Mongelluzzo J, Mohamad Z, Ten Have TR, Shah SS: Corticosteroids and mortality in children with bacterial meningitis. JAMA 2008, 299: 2048-2055. 10.1001/jama.299.17.2048CrossRefPubMed
12.
Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A: Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008, 336: 1006-1009. 10.1136/bmj.39537.939039.BEPubMedCentralCrossRefPubMed
13.
Metadata
Title
Recently published papers: Renal replacement therapy: which route and how much? Intracerebral haematomas: does the size matter? beta blockers and steroids: will we ever know?
Authors
Vlad Kushakovsky
Richard Venn
Publication date
01-08-2008
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2008
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc6968

Other articles of this Issue 4/2008

Critical Care 4/2008 Go to the issue

Research

Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release

Research

Prognostic value of brain natriuretic peptide in acute pulmonary embolism

Letter

The complications of percutaneous endoscopic gastrostomy

Review

Bench-to-bedside review: Latest results in hemorrhagic shock

Commentary

How to prevent leaky vessels during reperfusion? Just keep that glycocalyx sealant in place!

Commentary

A call to arms to reduce premature deaths by using inexpensive resuscitation care